×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PSNL – personalis, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PSNL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
11:44 am
psnl
Personalis (PSNL) had its price target lowered by Morgan Stanley from $11.00 to $10.00. They now have an "equal weight" rating on the stock.
Low
Report
Personalis (PSNL) had its price target lowered by Morgan Stanley from $11.00 to $10.00. They now have an "equal weight" rating on the stock.
2/27
08:02 am
psnl
Personalis (PSNL) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
Personalis (PSNL) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.
2/27
12:20 am
psnl
Personalis Inc (PSNL) Q4 2025 Earnings Call Highlights: Robust Clinical Growth Amidst Revenue ... [Yahoo! Finance]
Medium
Report
Personalis Inc (PSNL) Q4 2025 Earnings Call Highlights: Robust Clinical Growth Amidst Revenue ... [Yahoo! Finance]
2/26
11:47 pm
psnl
Personalis outlines 170% clinical test volume growth target for 2026 as reimbursement and MRD strategy accelerate [Seeking Alpha]
Medium
Report
Personalis outlines 170% clinical test volume growth target for 2026 as reimbursement and MRD strategy accelerate [Seeking Alpha]
2/26
11:39 pm
psnl
Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/26
04:54 pm
psnl
Personalis GAAP EPS of -$0.26 beats by $0.03, revenue of $17.35M beats by $0.23M [Seeking Alpha]
High
Report
Personalis GAAP EPS of -$0.26 beats by $0.03, revenue of $17.35M beats by $0.23M [Seeking Alpha]
2/26
04:14 pm
psnl
Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights [Yahoo! Finance]
High
Report
Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights [Yahoo! Finance]
2/26
04:01 pm
psnl
Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
Low
Report
Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/26
04:16 pm
psnl
Form 10-K Personalis, Inc. For: Dec 31
Low
Report
Form 10-K Personalis, Inc. For: Dec 31
2/26
04:07 pm
psnl
Form 8-K Personalis, Inc. For: Feb 26
Low
Report
Form 8-K Personalis, Inc. For: Feb 26
2/25
06:51 pm
psnl
Form 4 Personalis, Inc. For: Feb 23 Filed by: Tachibana Aaron
Medium
Report
Form 4 Personalis, Inc. For: Feb 23 Filed by: Tachibana Aaron
2/25
06:50 pm
psnl
Form 4 Personalis, Inc. For: Feb 23 Filed by: Chen Richard
Medium
Report
Form 4 Personalis, Inc. For: Feb 23 Filed by: Chen Richard
2/25
06:49 pm
psnl
Form 4 Personalis, Inc. For: Feb 23 Filed by: Moore Stephen Michael
Medium
Report
Form 4 Personalis, Inc. For: Feb 23 Filed by: Moore Stephen Michael
2/25
06:47 pm
psnl
Form 4 Personalis, Inc. For: Feb 23 Filed by: Hall Christopher M
Medium
Report
Form 4 Personalis, Inc. For: Feb 23 Filed by: Hall Christopher M
2/17
10:29 am
psnl
Form SCHEDULE 13G Personalis, Inc. Filed by: AMERIPRISE FINANCIAL INC
Low
Report
Form SCHEDULE 13G Personalis, Inc. Filed by: AMERIPRISE FINANCIAL INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/19
Form 3 Personalis, Inc. For: Jun 19 Filed by: Abingworth LLP
20.2%
3/19 Form 4 Personalis, Inc. For: Mar 17 Filed by: West John Stephen 17.0%
3/27 Form 4 Personalis, Inc. For: Mar 25 Filed by: Chen Richard 16.6%
3/25 Form 8-K Personalis, Inc. For: Mar 25 10.1%
4/3 Form DEF 14A Personalis, Inc. For: May 15 8.7%
3/18 Form 4 Personalis, Inc. For: Mar 16 Filed by: Tachibana Aaron 8.3%
11/12 Personalis, Inc. Expands Oncology Portfolio With the Launch of Cancer Whole Genome Sequencing Services 7.0%
12/5 Form 4 Personalis, Inc. For: Dec 03 Filed by: Chen Richard 6.9%
4/9 Personalis (NASDAQ: PSNL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.75 price target on the stock. 6.6%
4/23 Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020 6.2%
3/19 Form 4 Personalis, Inc. For: Mar 17 Filed by: West John Stephen 17.0%
3/27 Form 4 Personalis, Inc. For: Mar 25 Filed by: Chen Richard 16.6%
3/25 Form 8-K Personalis, Inc. For: Mar 25 10.1%
4/3 Form DEF 14A Personalis, Inc. For: May 15 8.7%
3/18 Form 4 Personalis, Inc. For: Mar 16 Filed by: Tachibana Aaron 8.3%
11/12 Personalis, Inc. Expands Oncology Portfolio With the Launch of Cancer Whole Genome Sequencing Services 7.0%
12/5 Form 4 Personalis, Inc. For: Dec 03 Filed by: Chen Richard 6.9%
4/9 Personalis (NASDAQ: PSNL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.75 price target on the stock. 6.6%
4/23 Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020 6.2%
TOP News Decliners
8/13
Q2/2019 6/30/2019 EPS -0.890 ZacksConsensus -0.310 ActVsEst (0.580) - Miss
-18.0%
3/11 Personalis to Announce Fourth Quarter and Full Year 2019 Financial Results on March 25, 2020 -15.8%
9/26 Form 8-K Personalis, Inc. For: Sep 25 -15.6%
10/1 2 Top Stocks That Aren't on Wall Street's Radar [The Motley Fool] -13.2%
11/13 Form 10-Q Personalis, Inc. For: Sep 30 -11.6%
9/9 Personalis, Inc. Enters Into Research Agreement With Invectys to Provide Comprehensive Tumor Immunogenomics Profiling for Clinical Trial -11.5%
9/26 Personalis (NASDAQ: PSNL) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. -9.4%
11/17 Personalis, Inc. to Present New Data at the AACR Tumor Immunology and Immunotherapy Conference -8.7%
7/15 Personalis (NASDAQ: PSNL) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -6.8%
2/11 Form 4 Personalis, Inc. For: Feb 07 Filed by: LUDLUM KEN -5.8%
3/11 Personalis to Announce Fourth Quarter and Full Year 2019 Financial Results on March 25, 2020 -15.8%
9/26 Form 8-K Personalis, Inc. For: Sep 25 -15.6%
10/1 2 Top Stocks That Aren't on Wall Street's Radar [The Motley Fool] -13.2%
11/13 Form 10-Q Personalis, Inc. For: Sep 30 -11.6%
9/9 Personalis, Inc. Enters Into Research Agreement With Invectys to Provide Comprehensive Tumor Immunogenomics Profiling for Clinical Trial -11.5%
9/26 Personalis (NASDAQ: PSNL) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. -9.4%
11/17 Personalis, Inc. to Present New Data at the AACR Tumor Immunology and Immunotherapy Conference -8.7%
7/15 Personalis (NASDAQ: PSNL) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -6.8%
2/11 Form 4 Personalis, Inc. For: Feb 07 Filed by: LUDLUM KEN -5.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: